Last reviewed · How we verify
Vitamin B combination
Vitamin B combination is a Small molecule drug developed by Duta Wacana Christian University. It is currently in Phase 3 development for Prevention and treatment of vitamin B deficiencies, Support for individuals with increased nutritional needs due to illness or pregnancy. Also known as: Vitamin B complex, Compound Vitamin B, Thiamine.
Vitamin B combination supplements provide essential vitamins that support various bodily functions, including energy production and nerve function.
Vitamin B combination, also known as Vitamin B complex, is a combination of vitamins that have been studied in various clinical trials for conditions such as nausea, clonal cytopenia of undetermined significance, and lymphomas. The combination includes vitamins such as pyridoxine (Vitamin B6) and ascorbic acid (Vitamin C), which have been used in interventions like Doxylamine + Pyridoxine and Diclectin.
-
Baseline phase 3 → approval rate
+58.3pp
Industry-wide phase 3 drugs reach approval ~58.3% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
| Regulator | Country | Likely year | Lag vs FDA |
|---|---|---|---|
| FDA | US | 2028–2030 | — |
| EMA | EU | 2029–2031 | +0.7 yr |
| MHRA | GB | 2029–2031 | +0.7 yr |
| Health Canada | CA | 2029–2032 | +0.9 yr |
| TGA | AU | 2029–2032 | +1.2 yr |
| PMDA | JP | 2029–2032 | +1.5 yr |
| NMPA | CN | 2030–2033 | +2.3 yr |
| MFDS | KR | 2029–2032 | +1.4 yr |
| CDSCO | IN | 2029–2033 | +1.8 yr |
| ANVISA | BR | 2030–2033 | +2.3 yr |
Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).
Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.
At a glance
| Generic name | Vitamin B combination |
|---|---|
| Also known as | Vitamin B complex, Compound Vitamin B, Thiamine |
| Sponsor | Duta Wacana Christian University |
| Modality | Small molecule |
| Therapeutic area | Nutritional Support |
| Phase | Phase 3 |
Mechanism of action
These combinations typically include vitamins B1, B2, B3, B6, B9, and B12, which play crucial roles in metabolic processes, red blood cell formation, and maintaining healthy neurological function.
Approved indications
- Prevention and treatment of vitamin B deficiencies
- Support for individuals with increased nutritional needs due to illness or pregnancy
Common side effects
- Nausea
- Headache
Key clinical trials
- A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions (PHASE3)
- Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia (PHASE2)
- Combination Gerotherapeutic Interventions for Healthspan Improvement (PHASE3)
- PentoxIfylline and Tocopherol for the Treatment of Post-radiotherapy Fibrosis in Head and Neck Cancer Patients (PHASE1)
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis (PHASE1, PHASE2)
- High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML) (PHASE1)
- All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma (PHASE2)
- Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vitamin B combination CI brief — competitive landscape report
- Vitamin B combination updates RSS · CI watch RSS
- Duta Wacana Christian University portfolio CI
Frequently asked questions about Vitamin B combination
What is Vitamin B combination?
How does Vitamin B combination work?
What is Vitamin B combination used for?
Who makes Vitamin B combination?
Is Vitamin B combination also known as anything else?
What development phase is Vitamin B combination in?
What are the side effects of Vitamin B combination?
Related
- Manufacturer: Duta Wacana Christian University — full pipeline
- Therapeutic area: All drugs in Nutritional Support
- Indication: Drugs for Prevention and treatment of vitamin B deficiencies
- Indication: Drugs for Support for individuals with increased nutritional needs due to illness or pregnancy
- Also known as: Vitamin B complex, Compound Vitamin B, Thiamine
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing